Abstracts by key term: Type 2 diabetes mellitus
The disease management programs (DMP) aim to improve medical care for chronically ill patients across the board. The goal of the treatment program is to coordinate patient treatment throughout the entire course of a chronic illness and across the boundaries of individual service providers and to optimize the patient's health based on medical evidence. On the one hand, it is about minimizing the “variance” of treatment by the practitioner (Glaeske 2011) and enabling treatment principles for treatment by the medical profession based on medical evidence. On the other hand, the patient should also be actively involved in the treatment process. In the doctor-patient interaction, treatment goals should be set in terms of lifestyle changes or the achievement of medical values. The treatment steps and the health condition are recorded in a documentation form by the treating doctor. As part of the legal evaluation of the DMP, service expenditure and survey data on health-related quality of life are also collected for a sample of patients. This data is linked and evaluated – in a pseudonymized form – at the individual level.
24.02.2012
The Federal Joint Committee (G-BA) recommends to the Federal Ministry of Health requirements for the design of disease management programs (DMP) for the statutory ordinance according to § 266 Para. 7 SGB V. The current status of medical science should be taken into account, taking into account evidence-based guidelines or the best available evidence for the respective care sector. The G-BA is also obliged to regularly check the DMP to ensure it is up to date. A last update of the DMP diabetes mellitus type 1 and type 2 was made by regulation in June 2009 (Federal Ministry of Health 2009). In December 2009, the Federal Joint Committee commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to carry out research for evidence-based guidelines on the subject of type 1 and type 2 diabetes mellitus. The recommendations extracted from the identified guidelines form the basis of the statutory update of the DMP diabetes mellitus.